Eye care giant Alcon acquires LumiThera, a Seattle-area startup behind device that treats vision loss LumiThera's key innovation is a device for use by ophthalmologists that improves vision and slows its loss, with a focus on patients with dry age-related macular degeneration.

Alcon acquires Seattle-based startup LumiThera, expanding its reach in tech-driven vision loss treatment. Big move in eye care innovation, check out the article:
www.geekwire.com/2025/eye-car...
#Alcon #LumiThera #VisionHealth #EyeCare

Kevin J. Corcoran, Corcoran Consulting Group, explains how to code photobiomodulation (PBM) of the retina. Read the full article here: ophthalmologymanagement.com/issues/2025/...
#coding #billing #PBM #photobiomodulation #LumiThera #Alcon #ophthalmology #eyecare

Alcon announced it will acquire LumiThera, Inc., a developer of photobiomodulation (PBM) therapy for dry AMD, in a move that broadens its retinal treatment portfolio beyond surgery. Learn more here: ow.ly/2MJR50WnyRO.
#dryAMD #Alcon #LumiThera #photobiomodulation #PBM